Clinical manifestations and misdiagnosis factors of pulmonary embolism patients seeking treatment in cardiology Authors: Doudou Yao, Wenjuan Cao, Xiaoyan Liu Published: 2024 ABSTRACT To explore the clinical manifestations and factors leading to misdiagnosis in pulmonary embolism (PE) patients in a cardiology department. We retrospectively analyzed 74 patients diagnosed with PE at our hospital from March 2018 to March 2022, comparing them to 136 patients suspected of PE but excluded by computed tomography pulmonary angiography during the same period. Both groups received the same basic care, including disease counseling, nutritional planning, and monitoring. We compared general information, clinical manifestations, risk factors, and auxiliary examinations to identify correlations between specific manifestations and misdiagnosis factors. The male-to-female ratio in the PE group was approximately 3:4, which was statistically significant compared to the control group (P < .05), though its impact on PE incidence was low. Common symptoms in the PE group included chest tightness, shortness of breath, sweating, and chest pain, with no significant difference from the control group (P > .05). Notable risk factors included deep vein thrombosis (DVT) (43.24%), prolonged bed rest (32.43%), lower limb varicose veins (18.92%), trauma (21.62%), pulmonary infections (62.16%), coronary heart disease (37.84%), respiratory failure (32.43%), and chronic obstructive pulmonary disease (13.51%). DVT was significantly associated with PE (P < .05). Multivariate logistic regression identified DVT (OR = 118.528, 95% CI: 6.959–2018.906, P = .001) and lower limb varicose veins (OR = 212.766, 95% CI: 6.584–6875.950, P = .003) as independent predictive factors for suspected PE. Clinical manifestations strongly correlated with PE included pulmonary rales, cyanosis, tachycardia, hypotension, elevated D-dimer, positive N-terminal pro-brain natriuretic peptide, and sinus tachycardia on echocardiogram. PE in cardiology patients may present with pulmonary rales, hypotension, shortness of breath, and abdominal symptoms, warranting reexamination for PE. Misdiagnosis factors typically involve chest pain, tightness, and shortness of breath. Lower limb varicose veins and DVT are reliable predictors of suspected PE. 1. Introduction Pulmonary embolism (PE) is a clinical and pathophysiological syndrome in which the pulmonary artery or its branches are blocked by endogenous and exogenous emboli. PE is a common and potentially fatal cardiovascular disease. The main mechanism of its occurrence is the detachment of blood clots in the bloodstream and their movement to the pulmonary blood vessels, ultimately leading to pulmonary vascular obstruction.[1] If this condition is not diagnosed and treated in a timely manner, it may rapidly deteriorate and even be fatal. PE includes pulmonary thromboembolism, fat, amniotic fluid, air embolisms, and other types. Due to the lack of suitable and simple noninvasive screening methods, the exact onset of PE is not yet fully understood.[2] Current data show that the incidence of asymptomatic PE ranges from 40% to 49%, and approximately 40% of PE patients seek medical attention in cardiology.[3,4] Most cardiology patients have basic diseases such as coronary heart disease, hypertension, and heart failure. Therefore, when the patient’s symptoms manifest as chest pain, chest tightness, etc, it is easy to cause misdiagnosis.[5] The nonspecific clinical manifestations of PE and the limitations of imaging examinations result in high misdiagnosis and missed diagnosis in cardiology. Long misdiagnosis and missed diagnosis are not conducive to the treatment and prognosis of patients, and even lead to patient death.[6] Therefore, early identification and accurate diagnosis of PE have important clinical significance. The study aims to explore in depth the clinical manifestations and misdiagnosis factors of PE patients in cardiology. By analyzing the clinical characteristics, auxiliary examination results, and prognosis of patients, this paper aims to find early diagnostic and differential diagnostic indicators. 2. Materials and methods 2.1. General information This study was approved by the Ethics Committee of Wuhan No. 4 Hospital. Figure 1 shows the general information involved. This study has been reviewed and approved by the hospital ethics committee. Schematic diagram of general patient information. 2.2. Research methods Plasma D-dimer detection method: immunoturbidimetric method is used to detect the D-dimer in the patient’s plasma, and professional nursing staff are arranged to collect blood from the test subject. After anticoagulant and centrifugation treatment, patients are tested on the machine.[7] Electrocardiogram detection: explain the purpose, process, and possible feelings of the electrocardiogram to the patient. Ensure that the power connection, electrodes, and wires of the electrocardiogram instrument are intact and undamaged. Clean the patient’s skin and gently wipe the area where the electrode is attached with an alcohol cotton ball or other cleaning agent. Firstly, observe whether the heart rate is normal and whether it is a normal sinus rhythm. Search for specific changes in electrocardiogram, including signs of right ventricular stress and abnormal inversion of T waves in different leads.[8] Echocardiogram (ECG) signs of right ventricular stress mainly include the following: (1) Right Bundle Branch Block. (2) S1Q3T3 mode: Deep S waves appear in the I lead, Q waves and inverted T waves appear in the III lead. (3) Right axis shift: the ECG axis shifts to the right. (4) Increased R-wave in V1 leads: a higher R-wave indicates right ventricular hypertrophy. (5) V1–V3 lead T wave inversion: common in acute right ventricular pressure increase. (6) Sinus tachycardia: an increased heart rate is usually a nonspecific manifestation of right ventricular stress. Echocardiogram detection: explain the purpose, process, and possible discomfort of echocardiography to patients. Let patients lie on the left side is beneficial for imaging the heart. Apply lead cream to the area where the probe comes into contact with the skin to reduce air gaps and improve imaging quality. The probe is usually first placed on the left edge of the sternum, and the technician adjusts the position and angle of the probe to obtain different views of the heart. Obtain 2D and Doppler images of the heart in various standard sections. Pay special attention to the size, shape, and function of the right ventricle, as well as the blood flow of the tricuspid valve and pulmonary valve.[9] Computed tomography pulmonary angiography (CTPA) detection: explain the purpose and process of CTPA to patients and inform them that contrast agents may be needed. Assess whether these patients are allergic to iodine contrast agents and whether their renal function is normal to ensure the safety of contrast agent use. Inject contrast agent through the patient’s intravenous catheter to enhance the imaging effect of blood vessels. Let patients lie flat on the sliding bed of the CT scanner, and according to the device’s instructions, they may need to raise their arms. During the scanning process, technicians guide patients on when to hold their breath through walkie talkies to reduce imaging blur. The CT machine rotates around the patient for rapid scanning, capturing high-resolution images of the pulmonary artery. By monitoring the distribution of contrast agent in blood vessels through computers, it is ensured that scanning begins when the contrast agent reaches the pulmonary artery. After the examination, patients may stay for a short time to ensure that there are no adverse reactions caused by the injection of contrast agents.[10] Other tests: plasma D-dimer, cardiac troponin T, and NT-proBNP are detected using electrochemical methods. Anticoagulant regimen: after diagnosis of TE, anticoagulant therapy is the key therapy that is immediately initiated to prevent further enlargement of blood clots and reduce the risk of recurrence. The initial treatment usually includes low-molecular weight heparin such as enoxaparin, administered through subcutaneous injection. The dosage is adjusted according to the patient’s weight. Heparin can also be administered as an option through subcutaneous or intravenous injection, and the dosage can be adjusted based on the patient’s activated partial thromboplastin time. Another option is to directly take direct oral anticoagulants, such as rivaroxaban or apixaban, which can be used directly without the need for load doses. After 4 to 5 days of initial treatment, vitamin K antagonists can be used for long-term anticoagulant therapy until the internationally standardized ratio stabilizes within the treatment interval for at least 24 hours. If patients are allergic to heparin or experience heparin induced thrombocytopenia, alternative drugs such as lysozyme or heparin should be used. direct oral anticoagulants can also be used in long-term management due to their advantages of fixed dosage and no need for monitoring.[11] Thrombolytic therapy: thrombolytic therapy is mainly aimed at TE patients who are life-threatening and have acute right ventricular failure. This type of treatment can quickly dissolve blood clots and restore blood flow. Patients suitable for thrombolytic therapy are usually hemodynamically unstable, such as those experiencing shock or sustained hypotension without a significant risk of bleeding. The commonly used thrombolytic drugs are tissue type plasminogen activators, such as ateplase, which are administered intravenously based on the patient’s body weight. This type of treatment should be carried out under close monitoring to observe whether the patient has any potential complications such as bleeding. Timely thrombolytic therapy can not only save the patient’s life, but also reduce the risk of long-term complications. However, patients still need to start anticoagulant therapy to avoid thrombosis recurrence.[11] 2.3. Observation indicators General information: include patient’s gender, age, height and weight, length of hospital stay, vital signs upon admission, type of suspected disease, and delayed diagnosis time. Risk factors: the risk factors of patients are observed, including strong, medium, and weak predisposing factors and the same risk factors as atherosclerosis. Strong predisposing factors include surgery, lower limb fractures, and joint replacement. Medium predisposing factors include malignant tumors, stroke, heart failure, respiratory failure, and deep vein thrombosis (DVT). Weak predisposing factors include patients lying in bed for more than 3 days, advanced age, and lower limb varicose veins. The same risk factors for atherosclerosis include smoking, obesity, hyperlipidemia, hypertension, diabetes, atrial fibrillation, and myocardial infarction within 3 months. Clinical manifestations: observe whether patients experience chest pain, hemoptysis, difficulty breathing, chest tightness, shortness of breath, palpitations, sweating profusely, blackness, fainting, coughing and sputum production, restlessness, panic, and a sense of impending death. Observe whether the patient’s respiratory rate is >20 beats per minute and whether the ventricular rate is >100 beats per minute. Observe whether the patient has signs such as wheezing rale, jugular vein filling, hypotension, pleural effusion, lower limb swelling, lower limb varicose veins, pulmonary valve area second heart sound hyperactivity or division, tricuspid valve area systolic murmur, etc. Combined basic diseases: observe whether the patient has hypertension, hyperlipidemia, heart failure, coronary heart disease, acute coronary syndrome (ACS), diabetes, chronic obstructive pulmonary disease, respiratory failure, stroke, malignant tumor, and other basic diseases. Auxiliary examinations: arterial blood gas analysis, plasma D-dimer, serum cardiac troponin T, N-terminal pro-brain natriuretic peptide (NT-proBNP). Imaging examinations include electrocardiogram, echocardiography, CTPA/magnetic resonance pulmonary angiography, etc. Treatment and prognosis: basic diagnosis and treatment plan will be given after admission. Anticoagulant and thrombolytic treatment plans will be given after diagnosis. The evaluation of good or poor prognosis is based on the patient’s improvement, discharge, or death. 2.4. Statistical methods The collected data are processed and analyzed using SPSS 25.0 statistical software. When the patient measurement data conform to a normal distribution, χ¯±s is used to represent them, and t test is used to complete the inter group comparison. The patient measurement data do not follow a normal distribution and are represented by the median. The component comparison is completed through Wilcoxon rank sum test. The counting data are expressed as a percentage and inter group comparison is completed through chi square test. Multivariate analysis is conducted using binary unconditional logistic regression analysis, with P < .05 indicating statistically significant differences in comparison. 3. Results 3.1. Comparison of general information between 2 groups of patients The general information comparison results of the 2 groups of patients are shown in Table 1. In the comparative analysis of general information between the 2 groups of patients, there was no statistically significant difference in age (t = 1.249, P = .213); no statistically significant difference in gender (χ2 = 3.753, P = .053); no statistically significant difference in body mass index (BMI) (χ2 = 1.519, P = .218); and no statistically significant difference in length of hospital stay (t = 1.431, P = .155). Table 1General information comparison.GroupStudy groupControl groupt/χ2 P Age (year)67.05 ± 13.1364.49 ± 14.751.249.213Gender (male/female)31/4376/603.753.053BMI (≥) 24 kg/m222 (29.73%)52 (38.24%)1.519.218Length of stay (day)9.57 ± 3.268.90 ± 3.111.431.155 General information comparison. 3.2. Research group suspected diagnosis The suspected and confirmed diagnosis results of patients admitted and discharged from the research group are shown in Table 2. In the research group, there was a statistically significant difference between the suspected diagnosis of admission and the confirmed diagnosis of discharge in patients with coronary heart disease (χ2 = 13.119, P < .001); there was a statistically significant difference between the suspected diagnosis of admission and the confirmed diagnosis of discharge in patients with heart failure (χ2 = 6.924, P = .009); and there was no statistically significant difference between the suspected diagnosis of admission and the confirmed diagnosis of discharge in patients with syncope (χ2 = 3.818, P = .051). Table 2Suspected diagnosis results of the study group.Diagnosis of disease typeNumber of casesConstituent ratioχ2 P Coronary heart diseaseAdmission diagnosis5067.57% (50/74)13.119.000Discharge diagnosis2837.84% (28/74)Heart failureAdmission diagnosis4459.46% (44/74)6.924.009Discharge diagnosis2837.84% (28/74)SwoonAdmission diagnosis2229.73% (22/74)3.818.051Discharge diagnosis1216.22% (12/74) Suspected diagnosis results of the study group. 3.3. Univariate analysis of 2 risk factors and combined underlying diseases We conducted a univariate analysis of risk factors and comorbidities between the study group (patients diagnosed with PE) and the control group (patients suspected of PE but later excluded). Results in Table 3 reveal significant differences in several risk factors and comorbidities between the 2 groups. The prevalence of DVT was substantially higher in the study group than in the control group (43.24% vs 2.94%, P < .001). Additionally, lower limb varicose veins and a history of traumatic surgery were also more common in the study group (both P < .001), suggesting these factors as potential predictors of PE. Chronic obstructive pulmonary disease, respiratory failure, and pulmonary infections were also more prevalent in the study group (P = .030, P = .040, and P = .022, respectively), further indicating an association between these chronic conditions and PE. Conversely, prolonged bed rest was more frequent in the control group (50.00% vs 32.43%, P = .014), possibly due to this group’s greater susceptibility to other non-PE conditions. Table 3Univariate analysis of risk factors and combined underlying diseases.Risk factor n(%)Study group (n = 74)Control group (n = 136)χ2 P Advanced age56 (75.68%)92 (67.65%)1.485.223DVT32 (43.24%)4 (2.94%)54.802 <.001 Stay in bed for more than 3 days24 (32.43%)68 (50.00%)6.008 .014 BMI ≥ 24 kg/m222 (29.73%)52 (38.24%)1.519.218Smoking18 (24.32%)50 (36.76%)3.387.066Lower limb varicose veins14 (18.92%)2 (1.47%)20.729<.001History of surgical trauma16 (21.62%)4 (2.94%)19.408 <.001 Hypertension48 (64.86%)72 (52.94%)2.782.095Pulmonary infection46 (62.16%)62 (45.59%)5.270 .022 Coronary heart disease28 (37.84%)80 (58.82%)8.449 .004 Heart failure28 (37.84%)50 (36.76%)0.024.878Respiratory failure24 (32.43%)20 (14.71%)0.046 .040 Hyperlipidemia16 (21.62%)26 (19.12%)0.188.665Diabetes16 (21.62%)22 (16.18%)0.959.328Acute myocardial infarction within 3 months14 (18.92%)22 (16.18%)0.254.614Atrial fibrillation14 (18.92%)34 (25.00%)1.005.316Liver and kidney dysfunction14 (18.92%)38 (27.94%)2.094.148COPD10 (13.51%)36 (26.47%)4.703 .030 Cerebral infarction8 (10.81%)26 (19.12%)2.437.118Valvular disease4 (5.41%)6 (4.41%)0.104.747Dilatation of heart disease2 (2.70%)6 (4.41%)0.382.537Cerebral hemorrhage2 (2.70%)4 (2.94%)0.010.921Malignant tumor2 (2.70%)2 (1.47%)0.389.533COPD = chronic obstructive pulmonary disease. Univariate analysis of risk factors and combined underlying diseases. COPD = chronic obstructive pulmonary disease. 3.4. Univariate analysis of clinical manifestations in 2 groups of patients The results of univariate analysis of clinical manifestations in 2 groups of patients are shown in Table 4. Table 5 shows the univariate analysis of clinical symptoms between 2 groups of patients. There is a statistically significant difference (P < .05) in the clinical manifestations of sweating, fainting, abdominal pain, and bloating between the 2 groups of patients; Table 4 shows a univariate analysis of the physical signs and symptoms of 2 groups of patients. The differences in the physical signs of lung rales, lower limb edema, cyanosis, tachycardia, hypotension, lower limb varicose veins, and heart murmurs between the 2 groups of patients were statistically significant (P < .05). Table 4Univariate analysis results of clinical manifestations.Univariate analysis of clinical symptomsStudy group (n = 74)Control group (n = 136)χ2 P Chest tightness52 (70.27%)95 (69.85%)0.004.950Shortness of breath47 (63.51%)79 (58.09%)0.588.443Sweat profusely27 (36.49%)26 (19.12%)7.662.006Chest pain25 (33.78%)63 (46.32%)3.095.079Syncope22 (29.73%)19 (13.97%)7.575.006Cough and sputum production22 (29.73%)43 (31.62%)0.080.777Dyspnea20 (27.03%)23 (16.91%)3.011.083Abdominal pain and bloating19 (25.68%)14 (10.29%)8.561.003Nausea and vomiting16 (21.62%)19 (13.97%)2.020.155Hemoptysis2 (2.70%)6 (4.41%)0.382.537 Univariate analysis results of clinical manifestations. Table 5Univariate analysis results of clinical manifestations.Univariate analysis of physical signs and symptomsStudy group (n = 74)Control group (n = 136)χ2 P Lung rale34 (45.95%)30 (22.06%)12.906.000Edema of lower extremities34 (44.74%)36 (26.47%)8.180.004Cyanoch roia32 (43.24%)18 (13.24%)23.789.000Tachycardia31 (41.89%)17 (12.50%)23.479.000Pleural effusion27 (36.49%)50 (36.76%)0.002.968Hypotension20 (27.03%)3 (2.21%)30.274.000Jugularvein distension9 (12.16%)2 (1.47%)11.036.001Shortness of breath5 (6.75%)2 (1.47%)4.530.033Cardiac murmur47 (63.51%)79 (58.09%)0.588.443 Univariate analysis results of clinical manifestations. 3.5. Comparison of auxiliary examinations between 2 groups of patients The comparison results of laboratory tests between the 2 groups of patients are shown in Table 6. The difference in CTnI between the 2 groups of patients was statistically significant (χ2 = 8.547, P = .003); the difference in D-dimer was statistically significant (χ2 = 47.743, P < .001); and the difference in NT-proBNP was statistically significant (χ2 = 21.433, P < .001). Table 6Univariate analysis of laboratory test results.Laboratory examinationStudy group (n = 74)Control group (n = 136)χ2 P CTnI62 (83.78%)88 (66.71%)8.547.003D-dimer64 (86.49%)50 (36.76%)47.743.000NT-proBNP62 (83.78%)70 (51.47%)21.433.000 Univariate analysis of laboratory test results. The comparison of electrocardiogram results between the 2 groups of patients is shown in Table 7. The difference in multi lead T wave inversion and atrial arrhythmia between the 2 groups of patients was not statistically significant (P > .05). The differences in right bundle branch block, right axis deviation, sinus tachycardia, and S1Q3T3 results between the 2 groups of patients were statistically significant (P < .05). Table 7Electrocardiogram results.Electrocardiogram resultStudy group (n = 74)Control group (n = 136)χ2 P Multilead T wave inversion32 (43.24%)56 (41.18%)0.084.772Sinus tachycardia24 (32.43%)14 (10.29%)15.848.000Atrial arrhythmia22 (29.72%)32 (23.52%)0.964.326Right bundle branch block18 (24.32%)14 (10.29%)7.304.007S1Q3T312 (16.21%)4 (2.941%)11.999.001The electrical axis is skewed to the right12 (16.21%)10 (7.35%)4.014.045 Electrocardiogram results. The comparison of echocardiography results between the 2 groups of patients is shown in Table 8. There was no statistically significant difference in the ultrasound signs of pulmonary arterial hypertension, left atrial enlargement, and right ventricular enlargement (P > .05). There was a statistically significant difference (P < .05) in the results of right atrial enlargement and tricuspid regurgitation between the 2 groups of patients. Table 8Echocardiogram results.Cardiac ultrasound indicatorsStudy group (n = 74)Control group (n = 136)χ2 P Pulmonary hypertension28 (37.83%)58 (42.60%)0.458.498Left atrial enlargement20 (27.03%)46 (33.82%)1.027.311Right atrial enlargement10 (13.51%)38 (27.94%)5.658.017Tricuspid regurgitation14 (18.92%)46 (33.82%)5.217.022Right ventricular enlargement18 (24.32%)36 (26.47%)0.116.734 Echocardiogram results. The comparison of CTPA examination results between the 2 groups of patients is shown in Table 9. There was no statistically significant difference in pneumonia, pleural effusion, and cardiac enlargement between the 2 groups of patients (P > .05). The difference in pulmonary valve dilation results was statistically significant (P < .05). Table 9CTPA/MRPA examination results.Image resultStudy group (n = 74)Control group (n = 136)χ2 P Pneumonia42 (56.78%)64 (47.06%)1.803.179Pleural effusion27 (36.49%)50 (36.76%)0.002.968Enlarged cardiac shadow24 (32.43%)46 (33.82%)0.042.838Dilatation of pulmonary trunk24 (32.43%)26 (19.12%)4.683.030CTPA = computed tomography pulmonary angiography, MRPA = magnetic resonance pulmonary angiography. CTPA/MRPA examination results. CTPA = computed tomography pulmonary angiography, MRPA = magnetic resonance pulmonary angiography. 3.6. Multi factor analysis of PE risk factors On the basis of univariate analysis, a multivariate analysis was conducted on the PE patients in the study group, and the results are shown in Table 10. In the study group, DVT (OR = 118.528, 95% CI: 6.959–2018.906, P = .001) and lower limb varicose veins (OR = 212.766, 95% CI: 6.584–6875.950, P = .003) were identified as independent factors for suspected PE in cardiology patients (P < .05). The clinical manifestations of pulmonary rales, cyanosis, tachycardia, and hypotension are significantly correlated with the diagnosis of PE in cardiology patients (P < .05). There is a significant correlation (P < .05) between the positive detection of D-dimer and NT-proBNP and the diagnosis of PE in cardiology patients. The electrocardiogram showed a significant correlation (P < .05) between sinus tachycardia and PE diagnosis in cardiology patients. Table 10Logistic regression analysis of risk factors for PE in cardiology.VariableβS.E.Waid P OR (95%CI)The female sex-0.1940.7740.063.8020.824 (0.181–3.758)DVT4.7751.44710.897.001118.528 (6.959–2018.906)Lower limb varicose veins5.3601.7739.137.003212.766 (6.584–6875.950)History of surgical trauma2.2921.3143.042.0819.891 (0.753–129.911)Coronary heart disease-1.5960.8843.258.0710.203 (0.036–1.147)Respiratory failure0.4291.0010.183.6691.535 (0.216–10.924)Sweating profusely1.2440.8592.098.1483.468 (0.645–18.659)Abdominal pain and distension0.4031.1020.134.7141.497 (0.173–12.979)Pulmonary rales1.8600.8175.180.0236.422 (1.295–31.855)Cyanosis2.8080.9169.397.00216.572 (2.752–99.773)Tachycardia2.8560.9838.434.00417.394 (2.531–119.549)Hypotension4.0351.3498.943.00356.529 (4.016–795.653)Tachypnea-0.2690.7260.137.7110.764 (0.184–3.173)D-dimer4.0551.15612.300.00057.681 (5.982–556.158)S1Q3T31.7291.4351.452.2285.634 (0.338–93.796)Sinus tachycardia3.8441.17610.694.00146.728 (4.666–467.979)NT-proBNP2.6720.9408.076.00414.471 (2.292–91.383) Logistic regression analysis of risk factors for PE in cardiology. 3.7. Comparison of prognosis of PE patients The prognosis of PE patients is divided into poor group and good group. The criteria for determining the poor prognosis of patients with PE are as follows: (1) hemodynamic instability. (2) Right ventricular dysfunction. (3) Abnormal arterial blood gas. (4) ECG manifestations of right ventricular stress. (5) Severe complications and the results are compared as shown in Table 11. There was a statistically significant difference in the clinical manifestations of dyspnea, cyanosis, persistent hypotension, and tachycardia between the good prognosis group and the poor prognosis group (P < .05). There was no significant difference between the 2 groups in basic diseases such as DVT, atrial fibrillation, cerebral hemorrhage, and diabetes (P > .05). Table 11Clinical data analysis of patients with different prognoses.Clinical dataPoor prognosis group (n = 14)Good prognosis group (n = 60)χ2 P Male6 (42.86%)24 (40.00%)0.038.845Advanced age10 (71.42%)48 (80.00%)0.492.483Dyspnea10 (71.42%)10 (16.67%)17.260.000Thoracodynia8 (57.14%)18 (30.00%)3.670.055Chest distress10 (71.42%)42 (70.00%)0.011.916Swoon6 (42.86%)16 (26.67%)1.424.233Sweating profusely4 (28.57%)24 (40.00%)0.630.427Abdominal pain and distension6 (42.86%)14 (23.33%)2.194.139Cyanosis12 (85.71%)20 (33.33%)12.690.000Hypotension8 (57.14%)10 (16.67%)10.103.001Pulmonary rales8 (57.14%)28 (46.67%)0.499.480The jugular vein is full4 (28.57%)12 (20.00%)0.492.483Tachycardia10 (71.42%)22 (36.67%)5.589.018DVT2 (14.29%)30 (50.00%)5.899.015Heart failure8 (57.14%)32 (53.33%)0.066.797Respiratory failure10 (71.42%)26 (43.33%)3.587.058Coronary heart disease8 (57.14%)20 (33.33%)2.736.098Hypertension.8 (57.14%)40 (66.67%)0.045.501Atrial fibrillation6 (42.86%)8 (13.33%)6.450.011Cerebral infarction2 (14.29%)8 (13.33%)0.009.925Cerebral hemorrhage2 (14.29%)1 (1.67%)4.647.031Diabetes6 (42.86%)10 (16.67%)4.595.032Liver and kidney dysfunction6 (42.86%)12 (20.00%)3.222.073 Clinical data analysis of patients with different prognoses. The results of the auxiliary examination data between the prognostic groups in Table 12 shows the results of electrocardiogram assisted examination data, and there is a statistically significant difference (P < .05) in T wave inversion and sinus tachycardia between the good prognosis group and the poor prognosis group in the electrocardiogram assisted examination data. Table 13 shows the results of blood gas analysis assisted examination data, and the differences in type I respiratory failure and hypocapnia data between the 2 groups are statistically significant (P < .05). Table 14 shows the auxiliary detection data of CTPA, and the difference in pulmonary artery trunk dilation data between the 2 groups is statistically significant (P < .05). Table 12Results of ECG assisted examination data.Symptom items ECG examinationPoor prognosis group (n = 14)Good prognosis group (n = 60)χ2 P Multi lead T wave inversion2 (14.29%)30 (50.00%)5.899.015Sinus tachycardia8 (57.14%)8 (13.33%)12.856.000Right branch block2 (14.29%)8 (13.33%)0.009.925S1Q3T32 (14.29%)5 (8.33%)0.470.493Electric axis deviation to the right2 (14.29%)5 (8.33%)0.470.493 Results of ECG assisted examination data. Table 13Results of blood gas analysis assisted examination data.Symptom items blood gas analysisPoor prognosis group (n = 14)Good prognosis group (n = 60)χ2 P Hypoxemia12 (85.71%)36 (60.00%)3.293.070Type I respiratory failure8 (57.14%)16 (26.67%)4.811.028Type II respiratory failure2 (14.29%)6 (10.00%)0.216.642Hypocapnia12 (85.71%)22 (6.11%)10.995.001 Results of blood gas analysis assisted examination data. Table 14Auxiliary detection data results of CTPA.Symptom items CTPA/MRPA examinationPoor prognosis group (n = 14)Good prognosis group (n = 60)χ2 P Bilateral pulmonary artery embolism4 (28.57%)34 (56.67%)3.587.058Left main pulmonary artery thrombus8 (57.14%)28 (46.67%)0.499.480Right main pulmonary artery thrombus1 (7.14%)14 (23.33%)1.841.175Pulmonary artery branch embolism2 (14.29%)14 (23.33%)0.548.459Dilation of pulmonary artery trunk10 (7.14%)14 (23.33%)11.982.001Pleural effusion4 (28.57%)24 (40.00%)0.630.427Heart shadow enlargement2 (14.29%)22 (36.67%)2.595.107Pneumonia6 (42.86%)36 (60.00%)1.359.244CTPA = computed tomography pulmonary angiography, MRPA = magnetic resonance pulmonary angiography. Auxiliary detection data results of CTPA. CTPA = computed tomography pulmonary angiography, MRPA = magnetic resonance pulmonary angiography. 4. Discussion In recent years, clinical physicians have improved their understanding of PE, and clinical diagnostic techniques have rapidly developed. The misdiagnosis rate and mortality rate of PE have both decreased globally. However, most patients in cardiology have underlying diseases such as hypertension, coronary heart disease, and heart failure. When patients exhibit symptoms such as persistent severe chest pain, chest tightness, and difficulty breathing, it is easy to be admitted to the hospital for suspected coronary heart disease, ACS, hypertensive crisis, acute aortic dissection, or acute heart failure. In addition, due to the limitations of early implementation of special imaging examinations such as CTPA, the missed diagnosis rate and misdiagnosis rate of PE in cardiology are still very high.[12,13] According to statistics, there are over 70 types of misdiagnosed diseases in PE, with the most common being coronary heart disease, pneumonia, congestive heart failure, and pleurisy.[14,15] Therefore, this study explores the clinical manifestations and misdiagnosis factors of TE patients who seek treatment in cardiology. At present, some studies believe that the gender of patients has a certain impact on the incidence rate of PE. Foreign studies have found that men are more likely to suffer from PE than women.[16–18] In China, the overall incidence rate of PE is about 0.1%. The incidence rate of PE in male patients is indeed slightly higher than that in female patients. Some studies also believe that the incidence of PE is not significantly different from the gender of patients.[19–21] In the research group, 37.8% of patients were admitted to the cardiology department due to suspected coronary heart disease, of which 16.2% were misdiagnosed as ACS and 37.8% were admitted due to suspected heart failure. This result is similar to similar studies.[22–24] The clinical manifestations of PE in the study were mostly unexplained sweating, fainting, abdominal pain, and bloating, and the differences in clinical manifestations were statistically significant (P < .05). There was a statistically significant difference in the signs of pulmonary rales, lower limb edema, cyanosis, tachycardia, hypotension, lower limb varicose veins, and heart murmurs between the 2 groups of patients (P < .05), indicating that it is very difficult to differentiate PE from common cardiovascular diseases such as coronary heart disease and ACS heart failure solely based on clinical symptoms and signs in actual clinical work. When PE patients have concurrent right heart dysfunction, CTnI and NT-proBNP results will also increase. Most patients receive secondary prevention of coronary heart disease or anticardiac therapy, but their symptoms do not improve. Further improvement of CTP examination is necessary before being diagnosed with APE. Therefore, the study suggests that common and frequently occurring diseases in cardiology are not independent predictors of suspected PE, such as coronary heart disease, hypertension, heart failure, etc. For patients with a clear history of coronary heart disease and presenting with chest pain and tightness as the initial symptom, as well as multi lead ST-T segment changes and elevated myocardial markers on electrocardiogram, physicians often tend to classify them as ACS, making it difficult to score according to the diagnostic process of PE, which can easily lead to misdiagnosis and missed diagnosis of such patients. After diagnosis by coronary CTA or coronary angiography, 37.84% of PE patients in the study had coronary heart disease, of which 18.92% had acute myocardial infarction combined with PE. Compared with the control group, the difference was statistically significant (P < .05). Partial research results indicate that myocardial infarction, ischemic stroke, and atrial fibrillation can to some extent predict the occurrence of VTE, and asymptomatic VTE patients have a higher risk of developing arterial thrombotic disease. The use of drugs that reduce the risk of arterial thrombosis can lower the risk of venous thrombosis, and vice versa. The study by Wu J et al confirmed that unilateral lower limb swelling and pain, history of DVT, and tachycardia are independent risk factors for APE in patients with coronary heart disease. Wells score combined with D-dimer testing has predictive value for the risk of APE in patients with coronary heart disease.[25] Therefore, for patients with coronary heart disease who seek medical attention in the cardiology department and have comorbidities such as advanced age, smoking, obesity, unilateral lower limb swelling and pain, tachycardia, a history of DVT, and elevated D-dimer test values, Wells or Geneva scores should be performed according to guidelines to be alert to the occurrence of APE. In the study, there was a significant difference (P < .05) between patients with coexisting respiratory failure in the PE group and the control group. Logistic regression analysis revealed a certain correlation between clinical manifestations such as shortness of breath, pulmonary sounds, and the occurrence of cardiology PE. The common symptoms of PE patients in the study include chest tightness, chest pain, shortness of breath, and profuse sweating. The common signs are pulmonary rales, lower limb edema, cyanosis, and tachycardia, which are similar to most existing research results.[26–28] In Harmindasatya C et al’s study, it was found that among patients hospitalized due to fainting episodes, there was a 16.7% probability of being PE patients, while 30% of PE patients who sought medical attention in cardiology presented with either blackout or fainting episodes, confirming that fainting is an independent risk factor for APE risk stratification.[29] In the correlation analysis of the study, hypotension, sinus tachycardia, and the occurrence of PE have a certain correlation. In the research results of Toupchiani S, it is also believed that heart rate not <100 beats per minute and hypotension are independent risk factors for the occurrence of complications in PE patients.[30] In the study, 86.49% of patients tested positive for plasma D-dimer, and the difference was statistically significant compared to the control group (P < .05). D-dimer, as a soluble degradation product of cross-linked fibrin, increases sharply during acute thrombosis. Logistic regression analysis showed that patients with positive plasma D-dimer test results were about 9 times more likely to be diagnosed with PE than those with negative results. Eighty-three point seven eight percent of patients tested positive for NT-proBNP and CTnI, indicating that NT-proBNP, as a highly sensitive biomarker of ventricular dysfunction, is associated with negative predictive values for mortality in APE patients. Therefore, echocardiography suggests that right ventricular dysfunction and elevated cardiac troponin, a marker of myocardial injury, are the main predictive factors for increased short-term mortality risk in APE patients. In summary, the clinical manifestations of chest pain, chest tightness, and shortness of breath in PE patients in cardiology lack specificity and are easily diagnosed as coronary heart disease, ACS, and heart failure. Clinical manifestations of pulmonary rales, hypotension, shortness of breath, and abdominal pain and bloating in patients with cardiology can serve as a diagnostic indicator for PE. D-dimer positivity, sinus tachycardia on electrocardiogram, and the occurrence of PE have a certain correlation. Traditional risk factors such as DVT and varicose veins are independent predictors of suspected PE in cardiology patients. The patient’s data on hypocapnia and pulmonary artery trunk dilation can be used as auxiliary data for PE diagnosis. As a retrospective study, this study has certain shortcomings. The subjective factors such as clinical manifestations of patients are greatly influenced by case writing. In the acute phase, the description of physical signs and auxiliary examination data may be incomplete, which may lead to errors in the analysis of relevant conclusions. Author contributions Conceptualization: Doudou Yao, Xiaoyan Liu. Data curation: Doudou Yao, Wenjuan Cao, Xiaoyan Liu. Formal analysis: Doudou Yao, Wenjuan Cao, Xiaoyan Liu. Writing – original draft: Doudou Yao, Wenjuan Cao, Xiaoyan Liu. Writing – review & editing: Doudou Yao, Xiaoyan Liu.